DUAL ACTION
Generic: ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/ 125 MG, ACETAMINOPHEN AND IBUPROFEN
Dr. Reddy's Laboratories IncManufacturer
ORALRoute
IBUPROFENActive Substance
2024-08-23Original Approval
DUAL ACTION is FDA application ANDA218247, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
47 reports
2
DRUG EFFECTIVE FOR UNAPPROVED INDICATION
30 reports
3
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
27 reports
4
DRUG EFFECT LESS THAN EXPECTED
15 reports
5
UNDERDOSE
13 reports
6
OVERDOSE
10 reports
7
INCORRECT DOSE ADMINISTERED
9 reports
8
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
8 reports
9
HYPERSENSITIVITY
7 reports
10
OFF LABEL USE
6 reports